Rici Healthcare Holdings Limited (HKG:1526)
Hong Kong · Delayed Price · Currency is HKD 1.100
-0.025 (-2.22%)
Aug 12, 2026, 4:08 PM HKT
Rici Healthcare Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,747 | 1,781 | 1,988 | 1,861 | 827 | 2,147 | |
Market Cap Growth | -0.14% | -10.40% | 6.84% | 125.00% | -61.48% | 64.63% |
Enterprise Value | 2,766 | 3,125 | 3,815 | 3,539 | 3,112 | 4,773 |
Last Close Price | 1.10 | 1.10 | 1.22 | 1.10 | 0.43 | 1.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.12 | 5.21 | 6.28 | 4.64 | 2.52 | 9.63 |
Forward PE | - | 148.75 | 148.75 | 148.75 | 148.75 | 148.75 |
PS Ratio | 0.56 | 0.57 | 0.64 | 0.56 | 0.31 | 0.74 |
PB Ratio | 0.91 | 0.93 | 1.36 | 1.52 | 0.81 | 2.98 |
P/TBV Ratio | 0.96 | 0.98 | 1.40 | 1.52 | 0.77 | 2.62 |
P/FCF Ratio | 2.79 | 2.85 | 3.19 | 3.47 | 1.85 | 4.91 |
P/OCF Ratio | 2.18 | 2.23 | 2.36 | 2.04 | 1.04 | 2.57 |
PEG Ratio | - | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.89 | 1.00 | 1.23 | 1.07 | 1.16 | 1.64 |
EV/EBITDA Ratio | 2.27 | 3.18 | 4.34 | 3.87 | 4.81 | 5.69 |
EV/EBIT Ratio | 3.66 | 4.13 | 5.72 | 4.89 | 6.37 | 7.47 |
EV/FCF Ratio | 4.42 | 5.00 | 6.13 | 6.60 | 6.95 | 10.91 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.17 | 1.17 | 1.67 | 2.04 | 2.54 | 4.67 |
Debt / EBITDA Ratio | 1.84 | 1.84 | 2.18 | 2.15 | 2.91 | 3.09 |
Debt / FCF Ratio | 3.58 | 3.58 | 3.93 | 4.65 | 5.80 | 7.70 |
Net Debt / Equity Ratio | 0.49 | 0.49 | 0.86 | 1.31 | 1.74 | 3.34 |
Net Debt / EBITDA Ratio | 0.95 | 0.95 | 1.44 | 1.75 | 2.76 | 2.87 |
Net Debt / FCF Ratio | 1.50 | 1.50 | 2.03 | 2.99 | 3.98 | 5.50 |
Asset Turnover | 0.57 | 0.57 | 0.62 | 0.65 | 0.52 | 0.54 |
Inventory Turnover | 34.45 | 34.45 | 36.68 | 34.17 | 24.60 | 24.86 |
Quick Ratio | 0.83 | 0.83 | 0.77 | 0.64 | 0.54 | 0.57 |
Current Ratio | 0.98 | 0.98 | 0.84 | 0.66 | 0.63 | 0.71 |
Return on Equity (ROE) | 24.75% | 24.75% | 28.50% | 39.82% | 32.59% | 63.86% |
Return on Assets (ROA) | 8.72% | 8.72% | 8.25% | 8.93% | 5.93% | 7.44% |
Return on Invested Capital (ROIC) | 17.91% | 17.92% | 17.92% | 19.18% | 12.76% | 14.98% |
Return on Capital Employed (ROCE) | 22.10% | 22.10% | 21.90% | 26.60% | 17.90% | 20.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 19.56% | 19.19% | 15.92% | 21.54% | 39.75% | 10.38% |
FCF Yield | 35.78% | 35.09% | 31.31% | 28.84% | 54.18% | 20.38% |
Dividend Yield | 1.78% | 1.83% | 3.68% | - | - | - |
Payout Ratio | - | - | 25.36% | 48.65% | - | - |
Total Shareholder Return | 1.79% | 1.83% | 3.68% | - | - | - |